MDL Formed for Depo-Provera Brain Tumor Cases: Judge M. Casey Rodgers to Lead Litigation

A Multi-District Litigation (MDL) has been formed to address thousands of lawsuits filed across the country involving Depo-Provera and its alleged link to meningioma brain tumors. This follows a new study revealing a significant connection between the prolonged use of birth control injections and the development of these tumors.

On Feb. 7, the Judicial Panel on Multi-District Litigation (JPML) officially consolidated these cases in the Northern District of Florida. The Honorable M. Casey Rodgers, renowned for presiding over the successful litigation involving defective military earplugs, has been appointed to oversee this MDL. Judge Rodgers’ experience with high-profile product liability cases, including the massive $6 billion settlement in the Combat Arms Earplugs litigation, will be instrumental in the efficient and fair resolution of these claims.

Rogers, Patrick, Westbrook & Brickman LLC (RPWB) Attorney Beth Burke, Esq. brings significant experience in mass tort cases and has worked extensively in front of Judge Rodgers. Burke previously co-chaired the plaintiff steering committee for the Combat Arms Earplugs case, which resulted in a landmark $6 billion settlement for military veterans and active service members exposed to faulty earplugs. Her deep understanding of complex litigation makes her a key player in the ongoing MDL for Depo-Provera brain tumor cases.

RPWB is actively accepting and filing cases into this newly-formed MDL on behalf of women who used Depo-Provera, a commonly administered birth control shot, and later developed meningioma brain tumors. These cases allege that the drug’s manufacturer, Pfizer Pharmaceuticals, failed to warn consumers about the risks associated with the prolonged use of Depo-Provera.

Depo-Provera is a widely used birth control injection that is administered every three months to prevent pregnancy. The injection contains medroxyprogesterone acetate, a synthetic hormone that prevents ovulation and thickens cervical mucus. However, new scientific research has raised serious concerns about the drug’s potential link to an increased risk of meningioma, a type of brain tumor that can result in severe health complications.

A 2024 study published in the British Medical Journal found that women who used Depo-Provera for more than one year were 5.6 times more likely to develop meningioma compared to those who did not use the drug. Meningiomas are the most common type of brain tumor, and while the majority are non-cancerous, they can cause significant complications, including neurological damage, loss of vision, and even death. The tumors often require surgery, radiation therapy, or other invasive medical interventions.

Women who have suffered from the long-term effects of Depo-Provera use and have been diagnosed with meningioma may be entitled to compensation. RPWB attorneys, including Beth Burke, Christiaan Marcum, and Aaron Dias, review cases and file claims for affected individuals.

If you or a loved one received Depo-Provera injections and have been diagnosed with meningioma, it is important to understand your legal rights. Contact Beth, Christiaan, or Aaron today to discuss your case and learn more about the legal options available to you. Call 843-727-6500 or complete our online form for a free consultation. RPWB is located in Charleston, Mt. Pleasant, Aiken, and Columbia, South Carolina, and serves clients throughout the state.

Please click here for more information or to read about Depo-Provera brain tumor cases.